Authors say insurance barrier poses risks to safety, health, and well-being

Potential years of life lost per death highest for deaths due to cancers of testis, bones/joints, other endocrine sites

About one in four meet combined goals of management of blood glucose, BP, non-HDL-C, avoiding smoking

Automated detection of impending clinical deterioration linked to lower mortality within 30 days after an alert

Nicotine e-cigarettes added to counseling improved abstinence at 12 weeks, but not at 24 weeks

Early results of clinical trial show high rate of responders who achieved ≥50 percent pain relief

Internet use lower among those with hypertension and diabetes and among Blacks and Hispanics

Reduction in HbA1c at 104 weeks greater with exenatide plus dapagliflozin versus either drug alone

Decreases seen for difficulty sleeping; chest pain or tightness; shortness of breath; cold or flu symptoms; and nausea, vomiting, or diarrhea

Risks for chronic kidney disease progression, CV events lower with finerenone versus placebo